Yanjiao Wu

机构：Hebei Medical University, Second Hospital of Hebei Medical University, First Hospital of China Medical University, China Medical University · ORCID：0000-0002-5827-0607

发表论文 43 篇 · 总被引 1058 次 · h-index 18

代表论文

• The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches (2023 · Basic Research in Cardiology · 被引 103)
• Advances in the study of exosomes in cardiovascular diseases (2023 · Journal of Advanced Research · 被引 82)
• Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches (2024 · Pharmacological Research · 被引 62)
• E3 Ubiquitin Ligase-Mediated Regulation of Osteoblast Differentiation and Bone Formation (2021 · Frontiers in Cell and Developmental Biology · 被引 33)
• Large-Volume Lateral Lymph Node Metastasis Predicts Worse Prognosis in Papillary Thyroid Carcinoma Patients With N1b (2022 · Frontiers in Endocrinology · 被引 31)
• The role of m6A methylation in osteosarcoma biological processes and its potential clinical value (2022 · Human Genomics · 被引 24)